Extensive suppuration and being overweight are factors associated with the failure of laser treatment for pilonidal disease: lessons from the first French retrospective cohort.
Minimally invasive technique
Pilonidal disease
Sinus laser therapy
Journal
Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
25
03
2021
accepted:
23
11
2021
pubmed:
3
12
2021
medline:
24
3
2022
entrez:
2
12
2021
Statut:
ppublish
Résumé
The aim of our study was to assess the efficacy of sinus laser therapy (SiLaT) for the treatment of pilonidal disease. All adult patients treated with SiLaT in our department between June 1, 2018, and August 23, 2019, were included in the study. Success was defined as the closure of cutaneous orifices and the absence of discharge or abscesses. We included 29 consecutive patients (22 males) with a median age of 32.5 ± 10.5 years. Eight patients had already undergone prior surgery for pilonidal disease. The procedure was performed under spinal (55%) or general (45%) anesthesia. The mean follow-up was 370.3 days (± 165.8 days). We observed 2 primary failures (6.9%) and 7 recurrences (24.1%). Ultimately, 20 patients were considered to have been cured (69%). The mean time to healing was 25 days (± 8.1 days). No serious complications were reported. Usual activities were resumed within a mean of 4.9 days (± 7.2), and 86% of patients reported being "very satisfied" with the treatment. The body mass index was lower for patients who were cured (24.0 ± 3.6) than for those who experienced treatment failure (27.6 ± 3.4; p = 0.018). The cured patients were less likely to have one or more secondary openings (35.0 versus 88.9%, p = 0.014). Almost 70% of our patients were cured by SiLaT. Complications were rare and mild. The technique appeared to be less effective for overweight patients and those with one or more secondary openings associated with pilonidal pits.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of our study was to assess the efficacy of sinus laser therapy (SiLaT) for the treatment of pilonidal disease.
METHODS
METHODS
All adult patients treated with SiLaT in our department between June 1, 2018, and August 23, 2019, were included in the study. Success was defined as the closure of cutaneous orifices and the absence of discharge or abscesses.
RESULTS
RESULTS
We included 29 consecutive patients (22 males) with a median age of 32.5 ± 10.5 years. Eight patients had already undergone prior surgery for pilonidal disease. The procedure was performed under spinal (55%) or general (45%) anesthesia. The mean follow-up was 370.3 days (± 165.8 days). We observed 2 primary failures (6.9%) and 7 recurrences (24.1%). Ultimately, 20 patients were considered to have been cured (69%). The mean time to healing was 25 days (± 8.1 days). No serious complications were reported. Usual activities were resumed within a mean of 4.9 days (± 7.2), and 86% of patients reported being "very satisfied" with the treatment. The body mass index was lower for patients who were cured (24.0 ± 3.6) than for those who experienced treatment failure (27.6 ± 3.4; p = 0.018). The cured patients were less likely to have one or more secondary openings (35.0 versus 88.9%, p = 0.014).
CONCLUSIONS
CONCLUSIONS
Almost 70% of our patients were cured by SiLaT. Complications were rare and mild. The technique appeared to be less effective for overweight patients and those with one or more secondary openings associated with pilonidal pits.
Identifiants
pubmed: 34855026
doi: 10.1007/s10151-021-02552-2
pii: 10.1007/s10151-021-02552-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
143-146Informations de copyright
© 2021. Springer Nature Switzerland AG.
Références
de Parades V, Bouchard D, Janier M (2013) Pilonidal sinus disease. J Visc Surg 150:237–247
doi: 10.1016/j.jviscsurg.2013.05.006
Johnson EK, Vogel JD, Cowan ML (2019) The American Society of Colon and Rectal Surgeons’ clinical practice guidelines for the management of pilonidal disease. Dis Colon Rectum 62:146–157
doi: 10.1097/DCR.0000000000001237
Al-Khamis A, McCallum I, King PM, Bruce J (2010) Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev CD006213
Wilhem A (2011) A new technique for sphincter-preserving anal fistula repair using a novel radial emitting laser probe. Tech Coloproctol 15:445–449
doi: 10.1007/s10151-011-0726-0
Dessily M, Charara F, Ralea S (2017) Pilonidal sinus destruction with a radial laser probe: technique and first Belgian experience. Acta Chir Belg 117:164–168
doi: 10.1080/00015458.2016.1272285
Georgiou GK (2016) Outpatient treatment of pilonidal disease with a 1470nm diode laser; initial experience. Int J Surg Surgical Porced 1:103
Pappas AF, Christodoulo DK (2018) A new minimally invasive treatment of pilonidal sinus disease with the use of a diode laser: a prospective large series of patients. Colorectal Dis 20:O207–O214
doi: 10.1111/codi.14285
Dessily M, Dziubeck M, Chahidi E (2019) The SiLaC procedure for pilonidal sinus disease: long-term outcomes of a single institution prospective study. Tech Coloproctol 23:1133–1140
doi: 10.1007/s10151-019-02119-2
Geogiou GK (2018) Outpatient laser treatment of primary pilonidal disease: the PiLaT technique. Tech Coloproctol 22:773–778
doi: 10.1007/s10151-018-1863-5
KayaalpC AC (2009) Review of phenol treatment in sacrococcygeal pilonidal disease. Tech Coloproctol 13:189–193
doi: 10.1007/s10151-009-0519-x
Lund J, Tou S, Doleman B, Williams JP (2017) Fibrin glue for pilonidal sinus disease (Review). Cochrane Database Syst Rev CD011923
Mostafaei S, Noro oznezhad F, Mohammadi S, Noro oznezhad AH (2017) Effectiveness of platelet-rich plasmatherapy in wound healing of pilonidal sinus surgery: a comprehensive systematic review and meta-analysis. Wound Repair Regen 25:1002–1007
doi: 10.1111/wrr.12597
Kuckelman JP (2018) Pilonidal disease: management and definitive treatment. Dis Colon Rectum 61:775–779
doi: 10.1097/DCR.0000000000001121